Sahrudaya Health Care (Mumbai) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-12-2024
- Paid Up Capital ₹ 0.92 M
as on 15-12-2024
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit 22.22%
(FY 2022)
- Ebitda 33.33%
(FY 2022)
- Net Worth -127.27%
(FY 2022)
- Total Assets -66.67%
(FY 2022)
About Sahrudaya Health Care (Mumbai)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.92 M, as per Ministry of Corporate Affairs (MCA) records.
Sushil Parakh, Annam Sharath, and Neeraj Jayaswal serve as directors at the Company.
- CIN/LLPIN
U85300TG2019PTC130459
- Company No.
130459
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Feb 2019
- Date of AGM
20 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sahrudaya Health Care (Mumbai)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sushil Parakh  | Director | 16-Sep-2022 | Current |
| Annam Sharath | Director | 11-Feb-2019 | Current |
| Neeraj Jayaswal | Director | 10-Sep-2021 | Current |
Financial Performance and Corporate Structure Insights of Sahrudaya Health Care (Mumbai).
Sahrudaya Health Care (Mumbai) Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 22.22% increase in profit. The company's net worth observed a substantial decline by a decrease of 127.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sahrudaya Health Care (Mumbai)?
In 2020, Sahrudaya Health Care (Mumbai) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Moi Health Care Private LimitedActive 8 years 1 month
Annam Sharath and Neeraj Jayaswal are mutual person
- Ashoka Medwell Private LimitedInactive For E-Filing 8 months 25 days
Sushil Parakh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sahrudaya Health Care (Mumbai)?
Unlock and access historical data on people associated with Sahrudaya Health Care (Mumbai), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sahrudaya Health Care (Mumbai), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sahrudaya Health Care (Mumbai)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
